Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells

Schizophrenia (SCZ) is a devastating mental disorder that is characterized by distortions in thinking, perception, emotion, language, sense of self, and behavior. Epidemiological evidence suggests that subtle perturbations in early neurodevelopment increase later susceptibility for disease, which ty...

Full description

Bibliographic Details
Main Authors: Ruhel Ahmad, Vincenza Sportelli, Michael Ziller, Dietmar Spengler, Anke Hoffmann
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Cells
Subjects:
Online Access:http://www.mdpi.com/2073-4409/7/9/140
_version_ 1797712070440910848
author Ruhel Ahmad
Vincenza Sportelli
Michael Ziller
Dietmar Spengler
Anke Hoffmann
author_facet Ruhel Ahmad
Vincenza Sportelli
Michael Ziller
Dietmar Spengler
Anke Hoffmann
author_sort Ruhel Ahmad
collection DOAJ
description Schizophrenia (SCZ) is a devastating mental disorder that is characterized by distortions in thinking, perception, emotion, language, sense of self, and behavior. Epidemiological evidence suggests that subtle perturbations in early neurodevelopment increase later susceptibility for disease, which typically manifests in adolescence to early adulthood. Early perturbations are thought to be significantly mediated through incompletely understood genetic risk factors. The advent of induced pluripotent stem cell (iPSC) technology allows for the in vitro analysis of disease-relevant neuronal cell types from the early stages of human brain development. Since iPSCs capture each donor’s genotype, comparison between neuronal cells derived from healthy and diseased individuals can provide important insights into the molecular and cellular basis of SCZ. In this review, we discuss results from an increasing number of iPSC-based SCZ/control studies that highlight alterations in neuronal differentiation, maturation, and neurotransmission in addition to perturbed mitochondrial function and micro-RNA expression. In light of this remarkable progress, we consider also ongoing challenges from the field of iPSC-based disease modeling that call for further improvements on the generation and design of patient-specific iPSC studies to ultimately progress from basic studies on SCZ to tailored treatments.
first_indexed 2024-03-12T07:16:21Z
format Article
id doaj.art-9684b131696c47bbbb4d08208fb4b039
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-12T07:16:21Z
publishDate 2018-09-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-9684b131696c47bbbb4d08208fb4b0392023-09-02T22:46:11ZengMDPI AGCells2073-44092018-09-017914010.3390/cells7090140cells7090140Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem CellsRuhel Ahmad0Vincenza Sportelli1Michael Ziller2Dietmar Spengler3Anke Hoffmann4Max Planck Institute of Psychiatry, Translational Psychiatry, 80804 Munich, GermanyMax Planck Institute of Psychiatry, Translational Psychiatry, 80804 Munich, GermanyMax Planck Institute of Psychiatry, Translational Psychiatry, 80804 Munich, GermanyMax Planck Institute of Psychiatry, Translational Psychiatry, 80804 Munich, GermanyMax Planck Institute of Psychiatry, Translational Psychiatry, 80804 Munich, GermanySchizophrenia (SCZ) is a devastating mental disorder that is characterized by distortions in thinking, perception, emotion, language, sense of self, and behavior. Epidemiological evidence suggests that subtle perturbations in early neurodevelopment increase later susceptibility for disease, which typically manifests in adolescence to early adulthood. Early perturbations are thought to be significantly mediated through incompletely understood genetic risk factors. The advent of induced pluripotent stem cell (iPSC) technology allows for the in vitro analysis of disease-relevant neuronal cell types from the early stages of human brain development. Since iPSCs capture each donor’s genotype, comparison between neuronal cells derived from healthy and diseased individuals can provide important insights into the molecular and cellular basis of SCZ. In this review, we discuss results from an increasing number of iPSC-based SCZ/control studies that highlight alterations in neuronal differentiation, maturation, and neurotransmission in addition to perturbed mitochondrial function and micro-RNA expression. In light of this remarkable progress, we consider also ongoing challenges from the field of iPSC-based disease modeling that call for further improvements on the generation and design of patient-specific iPSC studies to ultimately progress from basic studies on SCZ to tailored treatments.http://www.mdpi.com/2073-4409/7/9/140patient-specific iPSCsschizophreniaearly neurodevelopmentdifferentiationneurotransmissionmitochondriamicro-RNAneuroleptics
spellingShingle Ruhel Ahmad
Vincenza Sportelli
Michael Ziller
Dietmar Spengler
Anke Hoffmann
Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells
Cells
patient-specific iPSCs
schizophrenia
early neurodevelopment
differentiation
neurotransmission
mitochondria
micro-RNA
neuroleptics
title Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells
title_full Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells
title_fullStr Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells
title_full_unstemmed Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells
title_short Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells
title_sort tracing early neurodevelopment in schizophrenia with induced pluripotent stem cells
topic patient-specific iPSCs
schizophrenia
early neurodevelopment
differentiation
neurotransmission
mitochondria
micro-RNA
neuroleptics
url http://www.mdpi.com/2073-4409/7/9/140
work_keys_str_mv AT ruhelahmad tracingearlyneurodevelopmentinschizophreniawithinducedpluripotentstemcells
AT vincenzasportelli tracingearlyneurodevelopmentinschizophreniawithinducedpluripotentstemcells
AT michaelziller tracingearlyneurodevelopmentinschizophreniawithinducedpluripotentstemcells
AT dietmarspengler tracingearlyneurodevelopmentinschizophreniawithinducedpluripotentstemcells
AT ankehoffmann tracingearlyneurodevelopmentinschizophreniawithinducedpluripotentstemcells